-
My Account
In App
My Account
BSE Live
Jan 16, 16:01Prev. Close
1173.20
Open Price
1173.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:59Prev. Close
1173.90
Open Price
1179.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Epigral (in Rs. Cr.) | Mar 20 | Mar 19 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 140.99 | 242.29 | |
| Net CashFlow From Operating Activities | 164.68 | 261.35 | |
| Net Cash Used In Investing Activities | -363.21 | -217.30 | |
| Net Cash Used From Financing Activities | 69.41 | 85.09 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -129.12 | 129.14 | |
| Cash And Cash Equivalents Begin of Year | 129.21 | 0.07 | |
| Cash And Cash Equivalents End Of Year | 0.10 | 129.21 |
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
11.11.2025
Epigral Standalone September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
